Ronald C. Chen, MD, MPH - Radiation OncologyRonald C. Chen, MD, MPH - Radiation Oncology
Dr. Ronald C. Chen reviews medical content for Healthwise, a nonprofit organization with a mission to help people make better health decisions. Dr. Chen is a University of North Carolina Lineberger Comprehensive Cancer Center member and Associate Professor in the Department of Radiation Oncology at UNC-Chapel Hill in Chapel Hill, North Carolina. Dr. Chen is also the Director of the UNC CyberKnife Radiosurgery Program and Associate Director of Education at UNC Lineberger. Education and Training
MD: Harvard Medical School, Boston, MA, 2004
Internship in Internal Medicine: Massachusetts General Hospital, Boston, MA, 2004-2005
Resident in Radiation Oncology, Harvard Radiation Oncology Program, Boston, MA, 2005-2008
MPH: Harvard School of Public Health, Boston, MA, 2008
Chief Resident in Radiation Oncology, Harvard Radiation Oncology Program, Boston, MA, 2008-2009 CertificationsAmerican Board of Radiation, Radiation Oncology Academic AppointmentsCo-director, University of North Carolina Genitourinary Cancers Multidisciplinary Program, Chapel Hill, NC, 2016-present
Associate Director, University of North Carolina Cyberknife Program, Chapel Hill, NC, 2014-present
Clinical Assistant Professor, Department of Urology, University of North Carolina, Chapel Hill, NC, 2014-present
University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC
- Associate Director for Education, 2016-present
- Director of the Comparative Effectiveness Research Program, 2016-present
- Member, 2009-present
University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC
- Associate Chair for Education, 2016-present
- Associate Professor with Tenure, 2014-present
- Associate Professor, 2009-2014
Fellow, Cecil G. Sheps Center for Health Services Research, University of North Carolina, Chapel Hill, NC, 2009-present Financial DisclosureThe final approval of Healthwise content is always made by a clinician with no financial conflicts.
This reviewer reported no financial conflicts. |
|
|
|
|
|